Evolving Care of Heavily Treatment–Experienced Patients With HIV

Download All
Learn how to assess and manage challenging case scenarios featuring heavily treatment–experienced patients with HIV with a series of expert discussion videos and slides reviewing the latest data and guidelines.
Roger Bedimo, MD, MS, FACP
Joseph J. Eron, Jr., MD
Monica Gandhi, MD, MPH
Princy N. Kumar, MD, FIDSA, MACP
David A. Wohl, MD
Brian Wood, MD

Video Modules

In this call between colleagues, expert faculty discuss their approaches to assessing virologic failure in a patient with an extensive but incomplete treatment history, including recommendations on assessing adherence and determining which resistance tests are needed.

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Pharmacists: 0.5 contact hours (0.05 CEUs) Released: February 22, 2021 Expired: February 21, 2022

In this call between colleagues, expert faculty discuss how they approach ART optimization in a virologically suppressed patient with HIV and multiclass resistance, including a discussion of relevant guidelines and data.

Roger Bedimo, MD, MS, FACP David A. Wohl, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 24, 2021 Expired: March 23, 2022

In this call between colleagues, expert faculty discuss how they select next-line ART for a heavily treatment–experienced patient with multiclass drug resistance experiencing virologic failure; discussion includes current and future options for treating patients with multiclass drug resistance.

Joseph J. Eron, Jr., MD Monica Gandhi, MD, MPH Physicians: maximum of 0.5 AMA PRA Category 1 Credits Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 19, 2021 Expired: April 18, 2022

Downloadable Slidesets

Download this expert-authored slideset to review guidelines and key data on assessing virologic failure for patients with multiclass drug resistance.

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: February 22, 2021

Download this expert-authored slideset to review guidelines and key data on switching ART in a heavily-treatment experienced patient with HIV and multiclass drug resistance.

Roger Bedimo, MD, MS, FACP David A. Wohl, MD Released: March 24, 2021

Download this expert-authored slideset to review guidelines and key data on selecting next-line ART for a heavily-treatment experienced patient with multiclass drug resistance experiencing virologic failure.

Joseph J. Eron, Jr., MD Monica Gandhi, MD, MPH Released: April 19, 2021

ClinicalThought

Heavily treatment–experienced patients with HIV are increasingly less common. However, by nature these patients are more complex and challenging. Here are expert answers to your outstanding questions on managing these patients.

Roger Bedimo, MD, MS, FACP Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: June 2, 2021

Podcast

In this podcast, listen to Roger Bedimo, MD, MS, FACP; Princy N. Kumar, MD, FIDSA, MACP; and Brian Wood, MD, answer healthcare professionals’ questions on care of heavily treatment–experienced patients with HIV, including which assessments are needed and how to best incorporate the latest approved treatment options.

Roger Bedimo, MD, MS, FACP Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: June 15, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue